Mouse Study Hints at New Male Contraceptive: THURSDAY.

With a contraceptive, which would be given to healthy people, the ‘tolerance’ for unwanted effects is very low. The largest obstacle, though, is money, Hamlin said. ‘Foundation and federal government grants are almost non-existent for male contraceptives,’ he said. ‘For the pill, that financing was through philanthropist Katharine McCormick. But we’ve yet to discover our modern-day McCormick.’.. Mouse Study Hints at New ‘Male Contraceptive’: – THURSDAY, Oct. 1, 2015 – – A discovery in mice could pave the way to a reversible, nonhormonal type of contraceptive for men, researchers statement. The findings, published online Oct. 1 in the journal Science, add to efforts to build up the elusive ‘male tablet’ – – that is, a reliable but temporary form of contraception for men.announced today they have produced a strategic alliance to analyze, develop and commercialize best-in-class targeted tumor therapeutics focusing on programmed cell death, or apoptosis. The alliance will leverage Ascentage Pharma’s experience in structure-based little molecule style, lead optimization and preclinical development with 3SBio’s proven drug development and commercialization capabilities in China. Related StoriesFDA grants accelerated authorization for Tagrisso to treat sufferers with advanced NSCLCNew antenna-like device makes breast cancer surgery less difficult for surgeonsCrucial transformation in single DNA bottom predisposes children to aggressive form of cancer Under the conditions of the agreement, 3SBio will make a US$3 million equity investment in Ascentage Pharma.